Source comparison
CJC-1295 Recovery: Dosing Comparison
Low-Dose Maintenance 30 mcg/kg Once weekly 2–3× baseline 2–3 days 5–6 days Chronic injury recovery, tendinopathy studies Standard Recovery Protocol 60 mcg/kg Twice weekly 4–5× baseline 1.5–2 days 6–7 days Acute soft-tissue injury, post-surgical recovery models
This comparison does not assign a generated winner or score.
- Low-Dose Maintenance
- 30 mcg/kg
- Once weekly
- 2–3× baseline
- 2–3 days
- 5–6 days
- Chronic injury recovery, tendinopathy studies
- Standard Recovery Protocol
- 60 mcg/kg
- Twice weekly
- 4–5× baseline
- 1.5–2 days
- 6–7 days
- Acute soft-tissue injury, post-surgical recovery models
- High-Dose Research (clinical trials)
- 90 mcg/kg
- 5–8× baseline
- 1–2 days
- 7–8 days
- GH deficiency correction, metabolic disorder studies
- Single-Dose Pharmacokinetic Study
- Single injection
- 3–5× baseline (transient)
- 2 days
- 5 days (single-phase decline)
- PK/PD characterisation, half-life validation